Juniper Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch JNP and buy or sell other stocks, ETFs, and their options commission-free!

About JNP

Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. 

CEO
John R. Chiminski
CEOJohn R. Chiminski
Employees
Employees
Headquarters
Somerset, New Jersey
HeadquartersSomerset, New Jersey
Founded
1986
Founded1986
Employees
Employees

JNP Key Statistics

Market cap
127.71M
Market cap127.71M
Price-Earnings ratio
-115.00
Price-Earnings ratio-115.00
Dividend yield
Dividend yield
Average volume
81.86K
Average volume81.86K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$13.25
52 Week high$13.25
52 Week low
$4.30
52 Week low$4.30

Stock Snapshot

With a market cap of 127.71M, Juniper Pharmaceuticals(JNP) trades at $11.48. The stock has a price-to-earnings ratio of -115.00.

Juniper Pharmaceuticals(JNP) stock opened on 2026-03-13 at —. The price climbed to — and dipped to —.

Juniper Pharmaceuticals(JNP) shares are trading with a volume of 0, against a daily average of 81.86K.

During the past year, Juniper Pharmaceuticals(JNP) stock moved between $4.30 at its lowest and $13.25 at its peak.

During the past year, Juniper Pharmaceuticals(JNP) stock moved between $4.30 at its lowest and $13.25 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.